Bingham Osborn & Scarborough’s EMULEX CORP ELX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-43,074
Closed -$343K 120
2015
Q1
$343K Hold
43,074
0.04% 85
2014
Q4
$244K Hold
43,074
0.03% 104
2014
Q3
$213K Buy
43,074
+5,664
+15% +$30.7K 0.03% 110
2014
Q2
$213K Hold
37,410
0.03% 105
2014
Q1
$276K Buy
37,410
+5,664
+18% +$41.6K 0.04% 85
2013
Q4
$227K Buy
31,746
+15,873
+100% +$118K 0.03% 88
2013
Q3
$123K Hold
15,873
0.02% 90
2013
Q2
$103K Buy
+15,873
New +$99.8K 0.02% 89

Bingham Osborn & Scarborough's ELX Position: Q2 2015 in Review

Bingham Osborn & Scarborough sold out of EMULEX CORP (ELX) in Q2 2015, closing a stake of 43,074 shares — an estimated $343K sold.

Bingham Osborn & Scarborough first reported a position in ELX in Q2 2013 and held it in 8 quarters. The position peaked at $343K in Q1 2015. 0 funds tracked by Wall St. Rank hold ELX as of Q2 2015.

  • Bingham Osborn & Scarborough reported no remaining EMULEX CORP position as of Q2 2015 after selling out during the quarter.
  • Bingham Osborn & Scarborough sold 43,074 EMULEX CORP shares in Q2 2015, an estimated $343K.
  • Bingham Osborn & Scarborough first reported a position in EMULEX CORP in Q2 2013 and held it in 8 quarters.
  • Bingham Osborn & Scarborough's EMULEX CORP position peaked at $343K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held EMULEX CORP as of Q2 2015.

Based on Bingham Osborn & Scarborough's 13F filing for Q2 2015, filed 10 Aug 2015.